CLINICAL_TRIALS
trial_result
· 2019-02-06
Clinical Trial Update: Study of PK/PD, Safety and Tolerability of LIK066 in Patients With Decreased Renal Function. [Phase 2]
Summary
Phase 2 trial evaluating PK/PD, safety and tolerability of LIK066 in patients with decreased renal function has been completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Renal Impairment | Phase 2 | Status: COMPLETED | Results posted: 2019-02-06